JP2014209129A5 - - Google Patents

Download PDF

Info

Publication number
JP2014209129A5
JP2014209129A5 JP2014145082A JP2014145082A JP2014209129A5 JP 2014209129 A5 JP2014209129 A5 JP 2014209129A5 JP 2014145082 A JP2014145082 A JP 2014145082A JP 2014145082 A JP2014145082 A JP 2014145082A JP 2014209129 A5 JP2014209129 A5 JP 2014209129A5
Authority
JP
Japan
Prior art keywords
test substance
loaded
animal
inoculated
excluding humans
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014145082A
Other languages
English (en)
Japanese (ja)
Other versions
JP5836444B2 (ja
JP2014209129A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2014145082A priority Critical patent/JP5836444B2/ja
Priority claimed from JP2014145082A external-priority patent/JP5836444B2/ja
Publication of JP2014209129A publication Critical patent/JP2014209129A/ja
Publication of JP2014209129A5 publication Critical patent/JP2014209129A5/ja
Application granted granted Critical
Publication of JP5836444B2 publication Critical patent/JP5836444B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014145082A 2006-09-06 2014-07-15 被検物質の評価方法 Expired - Fee Related JP5836444B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2014145082A JP5836444B2 (ja) 2006-09-06 2014-07-15 被検物質の評価方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2006240924 2006-09-06
JP2006240924 2006-09-06
JP2014145082A JP5836444B2 (ja) 2006-09-06 2014-07-15 被検物質の評価方法

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2013048403A Division JP5806694B2 (ja) 2006-09-06 2013-03-11 研究、判定又は評価法

Publications (3)

Publication Number Publication Date
JP2014209129A JP2014209129A (ja) 2014-11-06
JP2014209129A5 true JP2014209129A5 (https=) 2015-03-26
JP5836444B2 JP5836444B2 (ja) 2015-12-24

Family

ID=39157262

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2008533183A Withdrawn JPWO2008029836A1 (ja) 2006-09-06 2007-09-05 研究、判定又は評価法
JP2013048403A Expired - Fee Related JP5806694B2 (ja) 2006-09-06 2013-03-11 研究、判定又は評価法
JP2014145082A Expired - Fee Related JP5836444B2 (ja) 2006-09-06 2014-07-15 被検物質の評価方法

Family Applications Before (2)

Application Number Title Priority Date Filing Date
JP2008533183A Withdrawn JPWO2008029836A1 (ja) 2006-09-06 2007-09-05 研究、判定又は評価法
JP2013048403A Expired - Fee Related JP5806694B2 (ja) 2006-09-06 2013-03-11 研究、判定又は評価法

Country Status (3)

Country Link
US (1) US7923254B2 (https=)
JP (3) JPWO2008029836A1 (https=)
WO (1) WO2008029836A1 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2075341A4 (en) * 2006-09-06 2010-09-08 Nippon Zoki Pharmaceutical Co METHOD FOR THE INVESTIGATION, DETERMINATION OR EVALUATION BY MEANS OF GENE EXPRESSION ANALYSIS
JP5229789B2 (ja) * 2007-02-27 2013-07-03 プリマハム株式会社 新規ストレスバイオマーカー及びその用途
JP5513802B2 (ja) * 2009-08-04 2014-06-04 ホーユー株式会社 等電点電気泳動用ゲル及び等電点電気泳動方法
WO2011162317A1 (ja) * 2010-06-25 2011-12-29 日本臓器製薬株式会社 被検物質の判定又は評価方法
DE102014204514A1 (de) * 2014-03-12 2015-09-17 NH DyeAGNOSTICS GmbH Verfahren und Kit zum Überwachen der Probenvorbereitung, von chemischen Markierungsreaktionen und von Antikörperreaktionen
TWI711456B (zh) * 2015-05-29 2020-12-01 日商日本臟器製藥股份有限公司 牛痘病毒接種炎症組織萃取物及其用途以及其判定或評估方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS53101515A (en) * 1977-02-17 1978-09-05 Nippon Zoki Pharmaceutical Co Medicine having anodyne * sedative and antiallergic activity and production thereof
CA2503810C (en) * 2002-10-31 2012-03-13 Kusuki Nishioka Therapeutic agent for fibromyalgia
AU2006221453B2 (en) * 2005-03-07 2011-08-25 Nippon Zoki Pharmaceutical Co., Ltd. Method for study, determination or evaluation

Similar Documents

Publication Publication Date Title
Bayesteh et al. XFEM fracture analysis of orthotropic functionally graded materials
JP2014209129A5 (https=)
Xi et al. Progress in translational research on intracerebral hemorrhage: is there an end in sight?
MX2019004931A (es) Comparacion disimetrica de valores de humedad subepidermica.
Matsumoto et al. Sigma (σ) receptors as potential therapeutic targets to mitigate psychostimulant effects
EA201790398A1 (ru) Способы лечения заболевания печени
CY1120390T1 (el) Συνθεση και μεθοδος για διαγνωση και θεραπεια ασθενειων που σχετιζονται με εκφυλισμο νευριτων
JP2017526437A5 (ja) 遠隔虚血コンディショニングを行うシステムが組み込まれている医療装置、医療装置を動作させる方法、コンピュータ可読記憶媒体、台、及び自動体外式除細動器
EP3563776A3 (en) Staples for generating and applying compression within a body
EP3043875A4 (en) Method to determine body's physiological response to physical exercise for assessing readiness and to provide feedback, and system for implementing the method
EA201591331A1 (ru) Антагонисты il-33 и их применение
CL2016002683A1 (es) Proteínas agonistas de los receptores de trail de cadena simple
CY1125938T1 (el) Θεραπεια με βλαστοκυτταρα σε παθολογιες του ενδομητριου
BR112015026122A2 (pt) métodos para usar interleucina-10 para tratar doenças e desordens
WO2014120975A8 (en) Antibody-mediated immunocontraception
BR112016004324A2 (pt) anticorpos
MX378857B (es) Celulas huespedes modificadas y usos de las mismas.
IL290817A (en) Methods for production of human recombinant arginase 1 and uses thereof
DK3146042T3 (da) Rekombinant klassisk svinepestvirus (CSFV) med substitution i E2-proteinets TAV-epitop
BR112015023350A2 (pt) método para solicitar uma interpretação de um registro médico, e, produto de programa de computador
EP3562400A4 (en) COMPUTER ASSISTED TOMOGRAPHY AND POSITIONING OF THE ANATOMY TO IMAGINE
BR112016004450A2 (pt) métodos para tratar uma doença, para aumentar a eficácia de um tratamento, para adiar e/ou prevenir desenvolvimento da reincidência e/ou resistência de uma doença, para aumentar a sensibilidade a um inibidor, para estender o período de sensibilidade a um inibidor e para estender a duração de resposta a um inibidor
BR112015028986A2 (pt) métodos para produzir partículas compreendendo proteínas terapêuticas
Aslam et al. The effect of vitamin c addition in andromed® dilution on procentage of motility and spermatozoa intact plasma membrane of aceh bull after freezing
Jung Using High-Probability Request Sequences for Young Children with Disabilities: A Review of the Literature